Register to chat with like-minded investors on our interactive forums.
Period:
Draw Mode:
| Volume | 786 |
|
|||||
| News | - | ||||||
| Day High | 1.68 | Low High |
|||||
| Day Low | 1.59 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Cumberland Pharmaceutical Inc | CPIX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.05 | -3.03% | 1.60 | 16:30:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 1.59 | 1.59 | 1.68 | 1.60 | 1.65 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 31 | 786 | $ 1.60 | $ 1,257 | - | 1.43 - 2.3587 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:00:00 | 271 | $ 1.60 | USD |
Cumberland Pharmaceutical Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 22.95M | 14.26M | - | 39.55M | -6.28M | -0.44 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Cumberland Pharmaceutical News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CPIX Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.72 | 1.72 | 1.49 | 1.57 | 3,875 | -0.12 | -6.98% |
| 1 Month | 1.89 | 1.89 | 1.49 | 1.72 | 8,288 | -0.29 | -15.34% |
| 3 Months | 1.93 | 2.2328 | 1.49 | 1.94 | 9,957 | -0.33 | -17.10% |
| 6 Months | 2.06 | 2.3587 | 1.49 | 1.91 | 12,010 | -0.46 | -22.33% |
| 1 Year | 1.88 | 2.3587 | 1.43 | 1.79 | 19,430 | -0.28 | -14.89% |
| 3 Years | 3.01 | 7.51 | 1.43 | 4.93 | 436,789 | -1.41 | -46.84% |
| 5 Years | 5.93 | 7.51 | 1.43 | 4.88 | 272,860 | -4.33 | -73.02% |
Cumberland Pharmaceutical Description
| Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development and commercialization of branded prescription pharmaceutical products. The company's primary target markets are hospital acute care, gastroenterology, rheumatology and oncology. The company promotes its approved products through its hospital, field and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived primarily from the product sales of FDA approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, RediTrex, Sancuso, Vaprisol and Vibativ.. |
